Healthcare is entering a new era shaped by artificial intelligence, digital transformation, consumer-focused care, and rapid innovation across the healthcare ecosystem. As industry leaders look for new ways to improve outcomes, enhance access, and build a more connected healthcare system, HLTH USA 2026 will bring together the people and ideas driving this transformation.
Taking place…
The Marcus Evans 11th Edition Medical Device Project and Portfolio Management conference will explore how MedTech leaders across portfolio, R&D & regulatory to translate strategy into measurable business outcomes. Sessions will explore responsible AI, capacity and capability planning, single-source-of-truth ecosystems, and Strategic Realization Offices that close the gap between executive expectations and delivery reality while…
The pharmaceutical supply chain is facing a rapidly changing environment shaped by global disruptions, evolving regulatory requirements, increasing product complexity, cybersecurity risks, and growing demands for speed and resilience. As companies look to strengthen their operations, building supply chains that are agile, responsive, streamlined, and secure has become a strategic priority.
Against this backdrop, Pharma…
The pharmaceutical and healthcare industries are entering a new era of technology-led transformation, with artificial intelligence, machine learning, data science, informatics, and advanced data management reshaping how medicines are discovered, developed, and delivered.
Against this backdrop, Digi-Tech Pharma & AI 2027 will bring together senior professionals, technology leaders, decision-makers, and innovators from the pharmaceutical, biotechnology,…
Shots
Pelareorep is gaining regulatory momentum through multiple FDA interactions and Fast Track designations, providing greater clarity around potential registration pathways and shaping Oncolytics’ clinical development and partnership strategy.
REO-033 could mark a pivotal step toward registration as the randomized study in RAS-mutant MSS metastatic colorectal cancer builds on encouraging clinical data and has the potential to become…
Shots:
This edition explores Tailored Therapy, Smarter Decisions: AI in Personalized Medicine, highlighting how artificial intelligence, machine learning, multi-omics, real-world data, and predictive analytics are transforming personalized medicine into a more precise, data-driven, and patient-centric approach to care, enabling better patient stratification, treatment selection, and clinical decision-making.
Through expert perspectives, feature stories, and industry insights,…
As clinical trials become increasingly complex and technology-driven, the need for smarter strategies, stronger collaborations, and patient-centric innovation has never been greater. From decentralized clinical trials and artificial intelligence to advanced data management and evolving regulatory frameworks, the clinical research landscape is undergoing a significant transformation.
Global Clinical Trials Connect 2027 aims to bring together…
BIOPLUS-INTERPHEX KOREA (BIX) 2026 is Korea's premier biopharmaceutical business event, bringing together global leaders across the entire biopharmaceutical value chain. Scheduled to take place from October 28-30, 2026, at COEX, Seoul, South Korea, the event serves as a platform for innovation, knowledge exchange, technology showcase, and strategic business partnerships.
From drug discovery and clinical development…
An Interview with Priyanka Joshi, Associate Scientist in Analytical Development
Introduction
Cancer remains one of the world's greatest healthcare challenges, driving scientists to develop more effective and precise treatment approaches. Among the most promising innovations are cell therapies, which harness the body's own immune system to fight cancer. Behind these advances are scientists working to…
The pharmaceutical industry is entering a new era where innovation is no longer driven by individual organisations alone. From drug discovery and clinical research to manufacturing, regulatory compliance, digital transformation, and global commercialisation, success increasingly depends on strategic partnerships that combine expertise, technology, and shared ambition.
The Global Pharma Partnering Summit 2026 serves as a…

